New campaign redefines prostate cancer screening with a simple blood test

New campaign redefines prostate cancer screening with a simple blood test

A diagram of the male reproductive organs with "Prostata" and "BPH" labeled, showing stages of prostate cancer in varying shades of blue.

New campaign redefines prostate cancer screening with a simple blood test

A new campaign is encouraging men to get checked for prostate cancer by clearing up common misconceptions. The 'Relax, It's a Blood Test' initiative, backed by Novartis, aims to ease fears about screening—especially the belief that it always involves a rectal exam. Instead, the focus is on a simple blood test that measures prostate-specific antigen (PSA).

The PSA test is often the first step in prostate cancer screening for many men. It checks for elevated levels of a protein produced by the prostate, though not all cancers raise PSA levels. Results above 4 ng/mL are usually flagged, but this isn't a definitive threshold—doctors consider the full clinical picture before recommending further tests.

Before taking the test, men are advised to avoid ejaculation for 24 to 48 hours and steer clear of intense exercise or testing during urinary symptoms. Even benign conditions can temporarily spike PSA, so a high result may simply require retesting under better conditions.

Screening guidelines have shifted over the past decade. In 2012, the US Preventive Services Task Force (USPSTF) discouraged routine PSA tests for all men. By 2026, most major health bodies—including the USPSTF, European Association of Urology (EAU), and American Urological Association (AUA)—now recommend shared decision-making. For average-risk men aged 50–70 with a life expectancy of at least 10 years, a discussion with a doctor comes first, followed by a PSA test if appropriate. Higher-risk groups, such as Black men or those with a family history, may start earlier.

The campaign features NFL stars Rob Gronkowski and George Kittle, along with coach Bruce Arians, to spread the message. Their involvement highlights the simplicity of the test and the importance of early detection.

The push for clearer screening guidelines comes after years of mixed advice, which left many men and doctors uncertain. Current recommendations focus on informed choices rather than routine testing. For those at average risk, a conversation with a healthcare provider remains the best starting point.

Neueste Nachrichten